Stevanato Group SpA

STVN · NYSE

$19.01−$0.01 (−0.05%)TodayMarket closed ·
Prev close $19.02

About STVN

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 6,010 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.

Employees
6,010
Headquarters
Piombino Dese, Padova
Listed
Jul 16, 2021
Sector
Health Care
Industry
Life Sciences Tools & Services

Leadership

Stevanato Group SpA executives
NameTitleSince
Franco Stevanato—2010
Sergio Stevanato——
Marco Lago—2020
Riccardo Butta——
Ugo Gay——
Carla Costa——
Michele Monico—2025
Raffaele Pace——
Mauro Stocchi——
Franco Moro—2019
Alvise Spinazzi——
Madhavan Balachandran——
Fabrizio Bonanni——
Fabio Buttignon——
William Federici——
Karen Flynn——
Donald Morel——
Luciano Santel——
Lisa Miles—2024

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Stevanato Group SpA suppliers and customers
CompanyRelationshipCorrelation
Stevanato Holding SrlSupplier and customer—
West Pharmaceutical WSTCustomer—
Iconovo ICO.STSupplier and customer—
medmix MEDX.SWSupplier and customer—
Universita Ca' Foscari di VeneziaSupplier and customer—
Universita degli Studi di Napoli Federico IISupplier and customer—
University of TrentoSupplier and customer—
DuPont de Nemours DDSupplier—
NiproSupplier—
Corning GLWSupplier—

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.